H2020-JTI-IMI2-2014-02-single-stage

Suggested coordinators

Organisations that coordinated the most funded projects under this call.

• LSHTM2 coordinated
• DH1 coordinated
• FOHM1 coordinated
• HP HEALTH SOLUTIONS GERMANY GMBH1 coordinated
• INSERM1 coordinated
• SVA1 coordinated
• VIBALOGICS1 coordinated

Strong partners

Frequent participants in this call’s funded projects (research, universities, public bodies, and mixed types).

• LSHTM3 projects · UK
• DH3 projects · UK
• INSERM3 projects · FR
• INMI3 projects · IT
• Janssen Vaccines (f.k.a. Crucell Holland B.V.)3 projects · NL
• UOXF3 projects · UK
• CHU Bordeaux2 projects · FR
• EMERGENCY ONG ONLUS2 projects · IT
• INSERM TRANSFERT SA2 projects · FR
• UBx2 projects · FR

Industry partners

Companies and SMEs that appear often in this call’s historical projects.

• Janssen Vaccines (f.k.a. Crucell Holland B.V.)3 projects · company
• INSERM TRANSFERT SA2 projects · company
• HP HEALTH SOLUTIONS GERMANY GMBH1 projects · sme
• VIBALOGICS1 projects · sme
• AJ INNUSCREEN GMBH1 projects · company
• ALERE1 projects · company
• ALTONA1 projects · company
• BAVARIAN NORDIC1 projects · company
• NEWLINK GENETICS CORP1 projects · company
• Clonit1 projects · sme
• CORIS BIOCONCEPT SPRL1 projects · sme
• JANSSEN PHARMACEUTICA NV1 projects · company

Typical consortium size

Derived from historical funded projects linked to this call.

Partners per project

median 6.5 · avg 8.25

range 3 – 18 organisations

Country spread (sample)

17 countries

4–9 partner organisations (from median 6.5 in this call’s projects) · 17 countries appear often in the participant sample

Similar past projects

Largest EU contributions in this call — useful references for consortium patterns.

• EBOVAC1€58,336,885
• EBOVAC2€22,790,820
• EBODAC€20,328,856
• EbolaMoDRAD€4,300,935
• VSV-EBOVAC€3,887,260
• FILODIAG€2,260,105
• Mofina€1,162,622
• EBOMAN€1,023,325